These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 27862281

  • 1. Comparison of the Rome IV and Rome III criteria for IBS diagnosis: A cross-sectional survey.
    Bai T, Xia J, Jiang Y, Cao H, Zhao Y, Zhang L, Wang H, Song J, Hou X.
    J Gastroenterol Hepatol; 2017 May; 32(5):1018-1025. PubMed ID: 27862281
    [Abstract] [Full Text] [Related]

  • 2. Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study.
    Vork L, Weerts ZZRM, Mujagic Z, Kruimel JW, Hesselink MAM, Muris JWM, Keszthelyi D, Jonkers DMAE, Masclee AAM.
    Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28804974
    [Abstract] [Full Text] [Related]

  • 3. Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.
    Engsbro AL, Begtrup LM, Kjeldsen J, Larsen PV, de Muckadell OS, Jarbøl DE, Bytzer P.
    Am J Gastroenterol; 2013 Jun; 108(6):972-80. PubMed ID: 23419383
    [Abstract] [Full Text] [Related]

  • 4. How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors.
    Aziz I, Törnblom H, Palsson OS, Whitehead WE, Simrén M.
    Am J Gastroenterol; 2018 Jul; 113(7):1017-1025. PubMed ID: 29880963
    [Abstract] [Full Text] [Related]

  • 5. What impact do Rome IV criteria have on patients with IBS in China?
    Wang B, Zhao W, Zhao C, Jin H, Zhang L, Chen Q, Wang B.
    Scand J Gastroenterol; 2019 Dec; 54(12):1433-1440. PubMed ID: 31829752
    [Abstract] [Full Text] [Related]

  • 6. [A comparison between Rome III and Rome II criteria in diagnosing irritable bowel syndrome].
    Wang AJ, Liao XH, Hu PJ, Liu SC, Xiong LS, Chen MH.
    Zhonghua Nei Ke Za Zhi; 2007 Aug; 46(8):644-7. PubMed ID: 17967234
    [Abstract] [Full Text] [Related]

  • 7. Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria.
    Black CJ, Yiannakou Y, Houghton LA, Ford AC.
    Clin Gastroenterol Hepatol; 2020 Feb; 18(2):392-398.e2. PubMed ID: 31154027
    [Abstract] [Full Text] [Related]

  • 8. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.
    Mikocka-Walus A, Turnbull D, Moulding N, Wilson I, Andrews JM, Holtmann G.
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1137-43. PubMed ID: 18070012
    [Abstract] [Full Text] [Related]

  • 9. Comparisons of the Rome III and Rome IV criteria for diagnosis of irritable bowel syndrome in Indian and Bangladeshi communities and internal shifts in the diagnostic categories of bowel disorders of gut-brain interactions.
    Ghoshal UC, Rahman MM, Pratap N, Misra A, Sarker SA, Hasan M, Bangdiwala SI, Palsson OS, Sperber AD.
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14579. PubMed ID: 37010834
    [Abstract] [Full Text] [Related]

  • 10. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis.
    Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC.
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):908-917. PubMed ID: 32702295
    [Abstract] [Full Text] [Related]

  • 11. Natural History and Disease Impact of Rome IV Vs Rome III Irritable Bowel Syndrome: A Longitudinal Follow-Up Study.
    Goodoory VC, Houghton LA, Yiannakou Y, Black CJ, Ford AC.
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):569-577.e3. PubMed ID: 33957271
    [Abstract] [Full Text] [Related]

  • 12. Impact of Rome IV criteria on the prevalence of post-infection irritable bowel syndrome.
    Breen-Lyles M, Decuir M, Byale A, Smith K, Grover M.
    Neurogastroenterol Motil; 2023 May; 35(5):e14532. PubMed ID: 36633303
    [Abstract] [Full Text] [Related]

  • 13. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.
    Yao X, Yang YS, Cui LH, Zhao KB, Zhang ZH, Peng LH, Guo X, Sun G, Shang J, Wang WF, Feng J, Huang Q.
    J Gastroenterol Hepatol; 2012 Apr; 27(4):760-5. PubMed ID: 21929652
    [Abstract] [Full Text] [Related]

  • 14. Quantifying Rome symptoms for diagnosis of the irritable bowel syndrome.
    Chang JY, Almazar AE, Richard Locke G, Larson JJ, Atkinson EJ, Talley NJ, Saito YA.
    Neurogastroenterol Motil; 2018 Sep; 30(9):e13356. PubMed ID: 29701271
    [Abstract] [Full Text] [Related]

  • 15. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study.
    Aziz I, Palsson OS, Törnblom H, Sperber AD, Whitehead WE, Simrén M.
    Lancet Gastroenterol Hepatol; 2018 Apr; 3(4):252-262. PubMed ID: 29396034
    [Abstract] [Full Text] [Related]

  • 16. The epidemiology of irritable bowel syndrome in Denmark. A population-based survey in adults ≤50 years of age.
    Krogsgaard LR, Engsbro AL, Bytzer P.
    Scand J Gastroenterol; 2013 May; 48(5):523-9. PubMed ID: 23506174
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and impact of Rome IV versus Rome III irritable bowel syndrome in patients with inflammatory bowel disease.
    Fairbrass KM, Selinger CP, Gracie DJ, Ford AC.
    Neurogastroenterol Motil; 2022 May; 34(5):e14256. PubMed ID: 34472157
    [Abstract] [Full Text] [Related]

  • 18. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.
    Ford AC, Bercik P, Morgan DG, Bolino C, Pintos-Sanchez MI, Moayyedi P.
    Gastroenterology; 2013 Dec; 145(6):1262-70.e1. PubMed ID: 23994201
    [Abstract] [Full Text] [Related]

  • 19. The epidemiology and quality of life of functional gastrointestinal disorders according to Rome III vs Rome IV criteria: A cross-sectional study in primary care.
    Chuah KH, Beh KH, Mahamad Rappek NA, Mahadeva S.
    J Dig Dis; 2021 Mar; 22(3):159-166. PubMed ID: 33595169
    [Abstract] [Full Text] [Related]

  • 20. Examination of competing diagnostic models of functional gastrointestinal disorders related to pain in children.
    Schurman JV, Karazsia BT, Friesen CA.
    Neurogastroenterol Motil; 2017 Nov; 29(11):. PubMed ID: 28656703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.